Results 11 to 20 of about 389 (236)

Targeting c-Met in the treatment of urologic neoplasms: Current status and challenges [PDF]

Frontiers in Oncology, 2023
At present, studies have found that c-Met is mainly involved in epithelial-mesenchymal transition (EMT) of tumor tissues in urologic neoplasms. Hepatocyte growth factor (HGF) combined with c-Met promotes the mitosis of tumor cells, and then induces ...
Kang Xin
exaly   +6 more sources

CAR-T Cells in the Treatment of Urologic Neoplasms: Present and Future [PDF]

Frontiers in Oncology, 2022
In recent years, with the breakthrough of CAR-T cells in the treatment of hematological tumors, they are increasingly being used to treat solid tumors, including urologic neoplasms.
Zhengchao Zhang, Zhang Zhengchao, Tong Jie   +2 more
exaly   +6 more sources

Microbiome in urologic neoplasms: focusing on tumor immunity

Frontiers in Immunology
Urological tumors are an important disease affecting global human health, and their pathogenesis and treatment have been the focus of medical research.
, Peiyue Luo, Luo Peiyue
exaly   +6 more sources

Acceptance of emerging renal oncocytic neoplasms: a survey of urologic pathologists [PDF]

Virchows Archiv Fur Pathologische Anatomie Und Physiologie Und Fur Klinische Medizin
AbstractOncocytic renal neoplasms are a major source of diagnostic challenge in genitourinary pathology; however, they are typically nonaggressive in general, raising the question of whether distinguishing different subtypes, including emerging entities, is necessary. Emerging entities recently described include eosinophilic solid and cystic renal cell
Sambit K Mohanty, Shilpy Jha, Daniel J Luthringer   +2 more
exaly   +4 more sources

Updates in Histologic Grading of Urologic Neoplasms [PDF]

Archives of Pathology & Laboratory Medicine, 2020
Context.— Tumor histology offers a composite view of the genetic, epigenetic, proteomic, and microenvironmental determinants of tumor biology. As a marker of tumor histology, histologic grading has persisted as a highly relevant factor in risk stratification and management of urologic neoplasms (ie, renal cell ...
Travis Rice‐Stitt, Aida Valencia‐Guerrero, Kristine M. Cornejo, Chin‐Lee Wu   +3 more
openalex   +3 more sources

The expression of apolipoproteina1 and its correlation with infiltration of urologic neoplasm [PDF]

Translational Cancer Research, 2020
To explore the differential expression of apolipoproteinA1 (APOA1) in urologic neoplasm patient compared with controls, as well as investigates whether APOA1 correlated with infiltration of urologic neoplasm.A total of 59 tissue sections of surgically-resected urologic neoplasm and 6 cases of normal tissue sections were collected.
Huihui Hu, Bei Gong, Man Zhang
openalex   +3 more sources

Global, regional, and National burden of urologic neoplasms from 1990 to 2021 and future projections to 2050, a comprehensive analysis for global burden of disease

Discover Oncology
Background Urologic neoplasms are considered to pose a serious threat to patients’ lives and quality of life. Analyzing and describing the global disease burden of urologic neoplasms is necessary.
Zhao Yang, Yu Xinyang, Xu Xiaoqing, Qi Yuanfu, Dai Xin   +4 more
doaj   +2 more sources

Diagnostic criteria for oncocytic renal neoplasms: a survey of urologic pathologists [PDF]

Human Pathology, 2017
Renal oncocytoma and chromophobe renal cell carcinoma (RCC) have been long recognized as distinct tumors; however, it remains unknown if uniform diagnostic criteria are used to distinguish these tumor types in practice. A survey was distributed to urologic pathologists regarding oncocytic tumors.
Sean R. Williamson, Ramya Gadde, Kiril Trpkov, Michelle S. Hirsch, John R. Srigley, Victor E. Reuter, Liang Cheng, Lakshmi P. Kunju, Ravi Barod, Craig Rogers, Brett Delahunt, Ondřej Hes, John N. Eble, Ming Zhou, Jesse K. McKenney, Guido Martignoni, Stewart Fleming, David J. Grignon, Holger Moch, Nilesh Gupta   +19 more
  +6 more sources

The Role of Exenterative Surgery in Advanced Urological Neoplasms

Current Urology, 2020
Pelvic exenterative surgery is both complex and challenging, especially in the setting of locally recurrent disease. In recent decades, improved surgical techniques have facilitated more extensive resection of both locally advanced and recurrent pelvic malignancies, but its role in urological cancer surgery is highly selective.
Colla Cunneen, Michael E. Kelly, Gregory J. Nason, Éanna J. Ryan, Ben Creavin, D. C. Winter   +5 more
openalex   +3 more sources

Leiomyomata of the genitourinary tract: A case series from the “rare urological neoplasm” registry [PDF]

Scandinavian Journal of Urology, 2012
Leiomyomata are benign neoplasms that are rarely encountered in the genitourinary tract outside the uterus. Pathological confirmation is always needed for definitive diagnosis, in order to rule out malignancies such as leiomyosarcoma. In cases of small leiomyomata, a surveillance strategy can be suggested, although the preferred approach is complete ...
Marco Oderda, Nicola Mondaini, Riccardo Bartoletti, Dario Vigna, Chiara Fiorito, Francesco Marson, Francesca Peraldo, Andrea Bosio, Francesca Maletta, Donatella Pacchioni, Paolo Gontero   +10 more
openalex   +4 more sources